VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 47 filers reported holding VENTYX BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,821,536 | -33.4% | 340,384 | -37.1% | 0.25% | -22.0% |
| Q2 2023 | $17,744,275 | -9.5% | 540,984 | -7.5% | 0.32% | -16.4% |
| Q1 2023 | $19,597,500 | -35.4% | 585,000 | -36.8% | 0.38% | -33.6% |
| Q4 2022 | $30,330,750 | +286.1% | 925,000 | +311.1% | 0.58% | +297.3% |
| Q3 2022 | $7,855,000 | -50.2% | 225,000 | -82.5% | 0.15% | -49.0% |
| Q2 2022 | $15,768,000 | -9.9% | 1,289,280 | 0.0% | 0.29% | +0.7% |
| Q1 2022 | $17,496,000 | -31.7% | 1,289,280 | 0.0% | 0.28% | -13.7% |
| Q4 2021 | $25,605,000 | – | 1,289,280 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |